127 related articles for article (PubMed ID: 81476)
21. [Cellular immunity in patients with melanoma].
Gorodinova VV; Kholenshed A; Babakova SV
Vopr Onkol; 1976; 22(12):3-5. PubMed ID: 1020253
[TBL] [Abstract][Full Text] [Related]
22. [Current developments concerning malignant skin melanoma].
Dargent M
Maroc Med; 1972 Oct; 52(561):571-86. PubMed ID: 4667467
[No Abstract] [Full Text] [Related]
23. In vitro lymphocyte reactivity to soluble tumor extracts in Sinclair melanoma swine.
Aultman MD; Hook RR
Int J Cancer; 1979 Nov; 24(5):673-8. PubMed ID: 528082
[No Abstract] [Full Text] [Related]
24. Regulation of autosensitisation to encephalitogenic myelin basic protein by macrophage-association and soluble antigen.
Steinman L; Cohen IR; Teitelbaum D; Arnon R
Nature; 1977 Jan; 265(5590):173-5. PubMed ID: 64932
[No Abstract] [Full Text] [Related]
25. Immunobiology of human cutaneous melanoma.
Cochran AJ; Wen DR; Stene M; Fairhurst MV; Hoon DS
Prog Clin Biol Res; 1988; 256():597-618. PubMed ID: 3368501
[No Abstract] [Full Text] [Related]
26. [Immune diagnosis of malignant diseases. X. Value of the electrophoresis mobility test in the diagnosis of broncho-pulmonary diseases].
Douwes FR
Onkologie; 1978 Apr; 1(2):79-84. PubMed ID: 82241
[TBL] [Abstract][Full Text] [Related]
27. Lymphocyte sensitization in childhood solid tumours and lymphoblastic leukaemia, measured by electrophoretic mobility test.
Lampert F; Nitzschke U; Zwergel T
Br J Cancer; 1977 Jun; 35(6):844-9. PubMed ID: 68784
[TBL] [Abstract][Full Text] [Related]
28. Some aspects of the immune defense against cancer. II. In vitro studies on human tumors.
Hellström I; Hellström KE
Cancer; 1971 Nov; 28(5):1269-71. PubMed ID: 5125674
[No Abstract] [Full Text] [Related]
29. Evidence for tumor-specific immunity in human malignant melanoma.
Nagel GA; Piessens WF; Stilmant MM; Lejeune F
Eur J Cancer (1965); 1971 Feb; 7(1):41-7. PubMed ID: 5576728
[No Abstract] [Full Text] [Related]
30. Cell-mediated immunity against malignant melanoma in monozygous twins.
Nagel GA; St Arneault G; Holland JF; Kirkpatrick D; Kirkpatrick R
Cancer Res; 1970 Jun; 30(6):1828-32. PubMed ID: 5466283
[No Abstract] [Full Text] [Related]
31. Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors.
Thompson JJ; Herlyn MF; Elder DE; Clark WH; Steplewski Z; Koprowski H
Am J Pathol; 1982 Jun; 107(3):357-61. PubMed ID: 6177248
[TBL] [Abstract][Full Text] [Related]
32. Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment.
Cochran AJ; Thomas CE; Spilg WG; Grant RM; Cameron-Mowat DE; Mackie RM; Lindop G
Yale J Biol Med; 1973 Dec; 46(5):650-4. PubMed ID: 4779137
[No Abstract] [Full Text] [Related]
33. [Immuno-diagnosis of malignant melanoma].
Szekeres G; Battyáni Z
Magy Onkol; 2003; 47(1):45-50. PubMed ID: 12704454
[TBL] [Abstract][Full Text] [Related]
34. [Identification of protein S 100 and melanoma-associated antigens in a comparative study of malignant melanoma and nevus pathology].
Monti M; Berti E; Cavicchini S; Paindelli MG; Terragni L
G Ital Dermatol Venereol; 1985; 120(4):297-306. PubMed ID: 3899920
[No Abstract] [Full Text] [Related]
35. Delayed cutaneous hypersensitivity reactions to melanoma antigen.
Holmes EC; Roth JA; Morton DL
Surgery; 1975 Aug; 78(2):160-4. PubMed ID: 1154259
[TBL] [Abstract][Full Text] [Related]
36. Electrophoretic mobility test (EMT): studies on lymphocyte response and mechanism of the test using a rat tumor model.
Harthus HP; Ax W
Immunobiology; 1981; 158(3):151-72. PubMed ID: 6163695
[TBL] [Abstract][Full Text] [Related]
37. Lymphocyte reactivity to allogeneic tumor antigens and myelin basic protein in gastric cancer patients.
Nakajima T; Chikamori M; Isojima K; Iwaguchi T
Gan; 1977 Aug; 68(4):449-57. PubMed ID: 80343
[No Abstract] [Full Text] [Related]
38. Evaluation of macrophage electrophoretic mobility (MEM) test as an indicator of cellular immunity in ocular tumours.
Rahi AH; Otiko G; Winder AF
Br J Ophthalmol; 1976 Aug; 60(8):589-93. PubMed ID: 61762
[TBL] [Abstract][Full Text] [Related]
39. Aspects of cellular immunity in multiple sclerosis. Antigen-reactivity of lymphocytes and lymphokine activity.
Meyer-Rienecker HJ; Jenssen HL; Werner H
J Neurol Sci; 1979 Jul; 42(2):173-86. PubMed ID: 90125
[TBL] [Abstract][Full Text] [Related]
40. [Clinical application of monoclonal antibodies to human malignant melanoma-associated antigens].
Kageshita T; Ishihara K
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1744-8. PubMed ID: 3899015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
